PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 2026Patterns0 citationsOpen Access

Modeling of longitudinal immune profiles reveals distinct immunogenic signatures following five COVID-19 vaccinations among people living with HIV

View Full Paper
CKChapin S. KorosecJCJessica M. ConwayVMVitaliy Matveev

Key Points

Key points are not available for this paper at this time.

Abstract

The immune response to vaccination is highly heterogeneous and arises from a dynamic interplay of immune components. Harnessing machine learning (ML) to learn immune interdependencies offers the potential not only to decode immune signatures linked to a specified comorbidity but also to reveal individualized patterns laying the groundwork for precision-guided vaccination and targeted clinical follow-up. We employ a random forest (RF) approach to classify informative differences in immunogenicity between older people living with HIV (PLWH) on antiretroviral therapy (ART) and an age-matched control group who received up to five SARS-CoV-2 vaccinations. RFs identify evidence for T helper 1 (Th1) imprinting and reveal novel distinguishing immune features, such as saliva-based antibody screening, as promising diagnostic tools (whereas serum IgG is not). Our modeling approach reveals a subset of PLWH whose immune signatures are indistinguishable from the HIV- control group, which we interpret as near-complete immune restoration from a longitudinal vaccine-elicited immunogenic perspective. To expand the utility of our findings, we generate privacy-preserving synthetic "virtual patients" that accurately approximate the original longitudinal immunologic data and show, via train-on-synthetic/test-on-real evaluation, that RF classifiers trained solely on virtual patients generalize to held-out real patients. Our results highlight the effectiveness in utilizing informative immune feature interdependencies for classification tasks and suggest broad impacts of ML applications for personalized vaccination strategies among high-risk populations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Korosec et al. (2026) studied this question.

synapsesocial.com/papers/6a0f13df06ecbe8334481f6chttps://doi.org/10.1016/j.patter.2025.101474
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1ROC Anatomy—Getting the Most Out of Your Diagnostic Test2019 · 21 citations
  2. 2The effect of timing of antiretroviral therapy on CD4+ T-cell reconstitution in the intestine of HIV-infected patients2015 · 38 citations
  3. 3Not just antibodies: B cells and T cells mediate immunity to COVID-192020 · 325 citations
  4. 4Antibodies, viruses and vaccines2002 · 642 citations
  5. 5HIV infection2015 · 639 citations